Vivos (RDGL) Total Debt Growth (3y) (2013 - 2019)
Vivos (RDGL) Total Debt Growth (3y) (2013 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | 0.11% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | -0.32% |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | 5.42% |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | 2.61% |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 33.10% |
| Dec 31, 2018 | 34.80% |
| Sep 30, 2018 | -68.73% |
| Mar 31, 2018 | -65.04% |
| Sep 30, 2017 | -9.17% |
| Jun 30, 2017 | -13.03% |
| Mar 31, 2017 | 3.13% |
| Dec 31, 2016 | -9.30% |
| Sep 30, 2016 | -2.10% |
| Jun 30, 2016 | 4.21% |
| Dec 31, 2015 | 146.16% |
| Sep 30, 2015 | 156.21% |
| Jun 30, 2015 | 240.14% |
| Mar 31, 2015 | 73.77% |
| Dec 31, 2014 | 345.34% |
| Jun 30, 2014 | 119.72% |
| Dec 31, 2013 | 107.28% |